A pyridoxal-phosphate protein. The enzyme, purified from the bacterium Delftia sp. HT23, also has activity against L-threo-3-hydroxyaspartate, L-erythro-3-hydroxyaspartate, and D-serine. Different from EC 4.3.1.20, erythro-3-hydroxy-L-aspartate ammonia-lyase and EC 4.3.1.16, threo-3-hydroxy-L-aspartate ammonia-lyase. Requires a divalent cation such as Mn2+, Co2+ or Ni2+.
The expected taxonomic range for this enzyme is: Bacteria, Archaea
A pyridoxal-phosphate protein. The enzyme, purified from the bacterium Delftia sp. HT23, also has activity against L-threo-3-hydroxyaspartate, L-erythro-3-hydroxyaspartate, and D-serine. Different from EC 4.3.1.20, erythro-3-hydroxy-L-aspartate ammonia-lyase and EC 4.3.1.16, threo-3-hydroxy-L-aspartate ammonia-lyase. Requires a divalent cation such as Mn2+, Co2+ or Ni2+.
Substrates: the substrate specificity of the enzyme is determined by the orientation of the Cbeta-OH at the active site, whose spatial arrangement is compatible with the 3R configuration of 3-hydroxyaspartate. The enzyme also catalyzes the dehydration of erythro-3-hydroxy-L-aspartate Products: -
one Mg2+ is located between His351 and Cys353 at the active site. The other Mg2+ is chelated by the beta-carboxyl O atom and the beta-hydroxyl O atom of erythro-3-hydroxy-D-aspartate, forming a erythro-3-hydroxy-D-aspartate-Mg2+ complex
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
CRYSTALLIZATION (Commentary)
ORGANISM
UNIPROT
LITERATURE
crystals of D-THA DH belong to space group I4-1-22, single-wavelength anomalous diffraction data are collected to a resolution of 2.0 A using synchrotron radiation
sitting drop or hanging drop vapor diffusion method at 20°C, crystal structures of the enzyme in complex with the inhibitor D-erythro-3-hydroxyaspartate, crystal structure of the poorly active H351A mutant complexed with its substrate L-erythro-3-hydroxyaspartate, and H351A mutant enzyme complexed with the reaction intermediate 2-amino maleic acid
optically pure synthesis of L-threo-3-hydroxyaspartate and D-threo-3-hydroxyaspartate, promising intermediates for the synthesis of beta-benzyloxyaspartate by using a purified enzyme as a biocatalyst for the resolution of racemic DL-threo-3-hydroxyaspartate and DL-erythro-3-hydroxyaspartate. Considering 50% of the theoretical maximum, efficient yields of L-threo-3-hydroxyaspartate (38.9 %) and D-erythro-3-hydroxyaspartate (48.9 %) as isolated crystals are achieved with more than 99 % enantiomeric excess
Structural insights into the substrate stereospecificity of D-threo-3-hydroxyaspartate dehydratase from Delftia sp. HT23 a useful enzyme for the synthesis of optically pure L-threo- and D-erythro-3-hydroxyaspartate